| Authors: |
Jones DC; ICC, Early Oncology R&D, AstraZeneca, Cambridge, UK desjones@hotmail.com.; Immunocore Ltd, Abingdon, UK., Irving L; Biologics Engineering, AstraZeneca, Cambridge, UK., Dudley R; ICC, Early Oncology R&D, AstraZeneca, Cambridge, UK., Blümli S; Biologics Engineering, AstraZeneca, Cambridge, UK., Wolny M; Biologics Engineering, AstraZeneca, Cambridge, UK., Chatzopoulou EI; ICC, Early Oncology R&D, AstraZeneca, Cambridge, UK., Pryts S; ICC, Early Oncology R&D, AstraZeneca, Gaithersburg, Maryland, USA., Ahuja S; Dynamic Omics, CGR, Discovery Sciences, R&D, AstraZeneca, Gaithersburg, Maryland, USA., Rees DG; Biologics Engineering, AstraZeneca, Cambridge, UK., Sandercock AM; Biologics Engineering, AstraZeneca, Cambridge, UK., Rajan S; Biologics Engineering, AstraZeneca, Gaithersburg, Maryland, USA., Varkey R; Biologics Engineering, AstraZeneca, Gaithersburg, Maryland, USA., Kierny M; Biologics Engineering, AstraZeneca, Gaithersburg, Maryland, USA., Kayserian A; Biologics Engineering, AstraZeneca, Gaithersburg, Maryland, USA., Mulgrew K; ICC, Early Oncology R&D, AstraZeneca, Gaithersburg, Maryland, USA., Bowyer G; ICC, Early Oncology R&D, AstraZeneca, Cambridge, UK., Songvilay S; ICC, Early Oncology R&D, AstraZeneca, Cambridge, UK., Bienkowska K; ICC, Early Oncology R&D, AstraZeneca, Cambridge, UK., Glover MS; Dynamic Omics, CGR, Discovery Sciences, R&D, AstraZeneca, Gaithersburg, Maryland, USA., Hess S; Dynamic Omics, CGR, Discovery Sciences, R&D, AstraZeneca, Gaithersburg, Maryland, USA., Dovedi SJ; ICC, Early Oncology R&D, AstraZeneca, Cambridge, UK., Wilkinson RW; ICC, Early Oncology R&D, AstraZeneca, Cambridge, UK.; Immunocore Ltd, Abingdon, UK., Arnaldez F; Early Oncology R&D, AstraZeneca, Gaithersburg, Maryland, USA., Cobbold M; ICC, Early Oncology R&D, AstraZeneca, Gaithersburg, Maryland, USA. |
